Optometrists in Pinon, AZ Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Dr. Joseph Gilbert Reyther, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Nr-4, 2 Miles East Of Pinon, Pinon Health Center, Pinon, AZ 86510 Phone: 928-725-9657 Fax: 928-725-9654 |
Chad J Preiss, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Navajo Route 4, Pinon, AZ 86510 Phone: 928-674-7001 Fax: 928-674-7705 |
Dr. David James Petrik, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: Navajo Route 4, Pinon Health Center, Pinon, AZ 86510 Phone: 928-725-3220 Fax: 928-725-3613 |
 Dr. Toni Lauren Zimmerman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Navajo Route 4, Pinon Health Center, Pinon, AZ 86510 Phone: 928-725-3220 |
News Archive
Fire safety experts announce statewide program to prevent camp fire injuries, forest fires
Accompanied by Smokey the Bear, burn and fire safety experts today announced a statewide program to prevent camp fire injuries and forest fires. The median age of camp fire victims is two years old and many injuries happen long after the fire is thought to be extinguished. Experts say most of the incidents are predictable and preventable.
miRagen and t2cure enter licensing agreement for microRNA 92 technology
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement
Researchers uncover the cause of scarring in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is one of the most challenging and frustrating diseases that pulmonologists face.
Cardinal Health Foundation to award $1 million grant to help U.S. hospitals
The Cardinal Health Foundation today announced that, for the fourth consecutive year, it will award more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.
Ponatinib offers new hope in drug-resistant leukemia
An investigational tyrosine kinase inhibitor, ponatinib, has shown high levels of activity in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
› Verified 3 days ago